Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Ordinary shares, nominal value $0.025 per share
-
Shares outstanding
-
61,526,414
-
Total 13F shares
-
30,892,511
-
Share change
-
-696,521
-
Total reported value
-
$299,454,602
-
Price per share
-
$9.72
-
Number of holders
-
32
-
Value change
-
-$7,759,389
-
Number of buys
-
12
-
Number of sells
-
10
Institutional Holders of GH Research PLC - Ordinary shares, nominal value $0.025 per share (GHRS) as of Q4 2022
As of 31 Dec 2022,
GH Research PLC - Ordinary shares, nominal value $0.025 per share (GHRS) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,892,511 shares.
The largest 10 holders included
BVF INC/IL, RA CAPITAL MANAGEMENT, L.P., FMR LLC, VR Adviser, LLC, RTW INVESTMENTS, LP, ORBIMED ADVISORS LLC, CITADEL ADVISORS LLC, Verition Fund Management LLC, Cormorant Asset Management, LP, and MORGAN STANLEY.
This page lists
32
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.